Literature DB >> 9629

Beta-blockade and mechanisms of disease.

J D Fitzgerald.   

Abstract

In this review an attempt has been made to define the contribution of beta-antagonists to out understanding of the mechanisms of disease. It is concluded that beta-antagonists, and propranolol in particular, have clarified mechanisms in angina pectoris, cardiac arrhythmias and some aspects of essential hypertension as well as hypertrophic obstructive cardiomyopathy. The study of beta-antagonists in anxiety states shows that they can help to define the somatic component but give no clue as to central mechanisms involved. There is no substantial evidence that beta-antogonists are of value in the psychoses and these negative findings suggest that disturbances of brain catecholamines contribute little to the pathogenesis of these conditions.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 9629

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  3 in total

1.  Sir James Black and propranolol. The role of the basic sciences in the history of cardiovascular pharmacology.

Authors:  M P Stapleton
Journal:  Tex Heart Inst J       Date:  1997

2.  Blockade of cardiac and renal beta-receptors by low dose propranolol in normal subjects. Clues to its antihypertensive effect.

Authors:  R Davies; T G Pickering; A Morganti; M Wilson; J H Laragh
Journal:  Br Heart J       Date:  1979-03

3.  Cardiovascular and sympathetic response to exercise after long-term beta-adrenergic blockade.

Authors:  A E Raine; T G Pickering
Journal:  Br Med J       Date:  1977-07-09
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.